3-hydroxyflavone has been researched along with Disbacteriosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, S; Hu, L; Jing, W; Lu, H; Wang, K; Wang, S; Zhao, X; Zhu, M | 1 |
| Davy, BM; Davy, KP; Hulver, MW; Liu, D; Neilson, AP; Rowley, TJ; Smithson, AT; Strat, KM; Tessem, JS | 1 |
1 review(s) available for 3-hydroxyflavone and Disbacteriosis
| Article | Year |
|---|---|
Mechanisms by which cocoa flavanols improve metabolic syndrome and related disorders.
Topics: Animals; Antioxidants; Cacao; Chocolate; Colon; Dietary Supplements; Dysbiosis; Evidence-Based Medicine; Flavonols; Functional Food; Gastrointestinal Microbiome; Glucose Intolerance; Humans; Intestinal Mucosa; Metabolic Syndrome; Seeds; Severity of Illness Index | 2016 |
1 other study(ies) available for 3-hydroxyflavone and Disbacteriosis
| Article | Year |
|---|---|
Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism.
Topics: Animals; Anti-Inflammatory Agents; Bacteria; Bile Acids and Salts; Caco-2 Cells; Colitis; Colon; Dextran Sulfate; Dysbiosis; Fecal Microbiota Transplantation; Feces; Flavonols; Gastrointestinal Microbiome; Humans; Interleukin-1beta; Male; Mice, Inbred C57BL; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Tumor Necrosis Factor-alpha | 2021 |